BPC-157 vs. TB-500: A Comparison of Research Mechanisms
Updated May 2026 · By the Onyx Biolabs Research Team · 8-minute read · For laboratory research use only
TL;DR
BPC-157 and TB-500 are the two most-researched recovery peptides, but they act on different biological pathways. BPC-157 (15-amino-acid sequence derived from gastric juice) drives angiogenesis — new blood vessel formation — making it the lead candidate in tissue-repair research. TB-500 (synthetic fragment of Thymosin Beta-4) drives cell migration and actin sequestration, supporting muscle and fascia recovery. Researchers commonly source them as a blend because the mechanisms are complementary, not redundant. Both are sold strictly for in-vitro and laboratory research, not human consumption.
Quick comparison: BPC-157 vs TB-500
| Attribute | BPC-157 | TB-500 (Thymosin Beta-4 fragment) |
|---|---|---|
| Molecular structure | 15-amino-acid pentadecapeptide | 17-amino-acid synthetic fragment of TB4 |
| Natural source | Body Protection Compound found in human gastric juice | Synthetic analog of Thymosin Beta-4 (43 AA full peptide) |
| Primary mechanism | Angiogenesis — new capillary formation | Actin sequestration — promotes cell migration |
| Research focus | Tendon, ligament, gut lining, vascular repair | Muscle fibers, fascia, systemic cellular recovery |
| Typical molecular weight | ~1,419 Da | ~889 Da (TB-500 fragment) |
| Stability post-reconstitution | ~28 days at 2–8°C | ~28 days at 2–8°C |
| Onyx Biolabs SKU | BPC-157 5mg / 10mg | Available in blend SKU |
| Combined blend | BPC-157 + TB-500 (Wolverine Blend) | |
What is BPC-157?
BPC-157 is a synthetic 15-amino-acid peptide sequence isolated from a protective protein in human gastric juice (Body Protection Compound). In preclinical research, BPC-157 is studied for its angiogenic effects — it stimulates the formation of new blood vessels (capillaries) in damaged tissue, which is the rate-limiting step in soft-tissue repair.
How BPC-157 works at the cellular level
BPC-157 upregulates the expression of VEGFR-2 (Vascular Endothelial Growth Factor Receptor 2) on endothelial cells. VEGFR-2 is the master switch for angiogenesis. With more receptors expressed, endothelial cells respond more strongly to circulating VEGF, sprouting new capillaries into hypoxic (oxygen-starved) tissue.
What BPC-157 is researched for
- Tendon and ligament repair — preclinical models show accelerated collagen organization at injury sites
- Gastrointestinal lining integrity — the original research focus, given the gastric-juice origin
- Vascular regeneration — bypass formation around occluded vessels in rodent studies
- Wound healing — faster closure and reduced scar tissue in animal studies
What is TB-500?
TB-500 is a synthetic 17-amino-acid fragment of Thymosin Beta-4 (TB4), a naturally occurring 43-amino-acid protein found in nearly every cell in the body. The 17-AA fragment retains the active region of the full peptide responsible for actin binding and is used in research because it’s cheaper to synthesize and more stable than full-length TB4.
How TB-500 works at the cellular level
TB-500 binds to and sequesters G-actin monomers, regulating the polymerization of actin filaments inside cells. Actin polymerization is what gives cells the ability to migrate, change shape, and remodel tissue. By controlling the pool of available G-actin, TB-500 enables coordinated cell movement to injury sites — the migration phase of tissue repair.
What TB-500 is researched for
- Muscle fiber repair — faster satellite cell migration into damaged myofiber sites in preclinical models
- Fascia and connective tissue — coordinated remodeling of dense connective matrices
- Cardiac tissue research — post-infarct repair models in rodents
- Inflammation modulation — downregulation of pro-inflammatory cytokine cascades
BPC-157 vs TB-500: head-to-head differences
Mechanism: angiogenesis vs migration
BPC-157 builds new blood supply; TB-500 mobilizes cells to use it. These are sequential phases of tissue repair, not competing approaches. A tear in a tendon needs both new capillaries (BPC-157) and migrated repair cells (TB-500) to organize the new collagen.
Speed of effect in research models
BPC-157 effects on vascular sprouting are typically observed within 7–14 days in preclinical models. TB-500 effects on cell migration are observed within 4–7 days. The two timelines explain why blend protocols dominate the published research.
Tissue specificity
BPC-157 shows the strongest data in localized tissue repair (tendon, gut, vessel). TB-500 shows broader systemic effects across muscle and fascia. Researchers studying focal injuries (Achilles tear, ulcer) typically prioritize BPC-157; researchers studying systemic recovery prioritize TB-500.
Cost and dosing in research
BPC-157 is typically dosed in research at 5–10 mg/vial. TB-500 is dosed at 2–5 mg/vial. On a per-mg basis, TB-500 is more expensive due to its larger and harder-to-synthesize sequence.
Why researchers combine them: the “Wolverine Blend”
The combination of BPC-157 + TB-500 is the most-purchased blend in the research-peptide market because the mechanisms are sequential and complementary. New blood vessels form (BPC-157), then repair cells migrate to the injury site through those vessels (TB-500), then collagen reorganizes. A blend protocol covers the full repair cascade in one reconstitution.
Onyx Biolabs sells the blend as BPC-157 & TB-500 (Wolverine Blend), with both compounds verified at 99%+ purity via independent third-party HPLC and Mass Spec at Kovera Labs. View the current COA archive.
Storage and reconstitution
Both BPC-157 and TB-500 are shipped as lyophilized (freeze-dried) powders. Store unreconstituted vials at room temperature for short-term (under 60 days) or refrigerated at 2–8°C for long-term. After reconstitution with bacteriostatic water, both peptides are stable at 2–8°C for approximately 28 days.
For the full reconstitution protocol, see How to Reconstitute Research Peptides. For storage details, see Peptide Stability Guide.
How to verify purity
Every research-peptide vial should ship with a current Certificate of Analysis (COA) from an independent lab. Onyx Biolabs publishes COAs from Kovera Labs for every batch, showing HPLC purity (typically 99.4–99.9%) and Mass Spec identity confirmation. Read the guide on interpreting COAs.
Frequently asked questions
Is BPC-157 stronger than TB-500?
Neither is “stronger” — they act on different phases of tissue repair. BPC-157 builds new blood vessels (angiogenesis); TB-500 enables cell migration through those vessels. Comparing potency between them is like comparing a hammer to a screwdriver. Most research protocols use both because the effects are sequential.
Can BPC-157 and TB-500 be reconstituted in the same vial?
In research blend protocols, yes — pre-blended vials (like the Wolverine Blend) are reconstituted as a single solution with bacteriostatic water. The two peptides are chemically stable together and have similar shelf-life profiles after reconstitution (~28 days refrigerated).
How is BPC-157 purity verified?
By independent third-party testing using two methods: HPLC (high-performance liquid chromatography) measures the purity percentage, and Mass Spec confirms the molecular identity matches the expected 1,419 Da BPC-157 sequence. Onyx Biolabs publishes both for every batch.
What is the molecular weight of BPC-157?
BPC-157 has a molecular weight of approximately 1,419.53 Daltons. This is one of the data points confirmed on every Mass Spec report — if the measured mass doesn’t match this within +/- 1 Da, the compound is not authentic BPC-157.
What is the molecular weight of TB-500?
The 17-amino-acid TB-500 research fragment has a molecular weight of approximately 889 Daltons. The full-length Thymosin Beta-4 protein is ~4,963 Daltons. Make sure the COA on any TB-500 vial confirms the fragment mass, not the full protein mass.
Is TB-500 the same as Thymosin Beta-4?
No. TB-500 is a 17-amino-acid synthetic fragment of the active region of Thymosin Beta-4 (a 43-AA naturally occurring protein). The fragment retains the actin-binding activity of the full peptide but is cheaper and more stable.
How long do BPC-157 and TB-500 stay stable after reconstitution?
Both peptides remain stable for approximately 28 days when stored at 2–8°C (standard refrigeration) after reconstitution with bacteriostatic water. Freezing reconstituted peptides is not recommended — the freeze-thaw cycle can degrade the amino acid chain.
Where can I buy BPC-157 and TB-500 for research?
Onyx Biolabs sells both individually and as a blend, all with 99%+ verified purity and current third-party COAs. Browse the catalog: BPC-157 · BPC-157 + TB-500 Wolverine Blend.
Are BPC-157 and TB-500 legal in the United States?
Both compounds are sold legally in the United States as research chemicals for in-vitro and laboratory use only. They are not approved by the FDA for human consumption and are not sold for that purpose. Onyx Biolabs is a chemical supplier, not a compounding pharmacy or 503A/503B facility.
Disclaimer
For research, laboratory, or analytical use only. The compounds discussed are not approved for human or animal consumption. The statements on this page have not been evaluated by the FDA. Onyx Biolabs is a chemical supplier and is not a compounding pharmacy or chemical compounding facility as defined under 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Researchers are responsible for compliance with all applicable laws governing the handling and use of research compounds in their jurisdiction.